Exergen Corporation, a global leader in infrared temperature measurement technologies for medical applications, announced today that Oxygen Care has supplied
Phase 2b dose-finding study showed that delgocitinib cream demonstrated a statistically significant dose-response relationship compared with vehicle in adults with
XELJANZ 11mg prolonged-release tablets provide RA patients a once-daily dosing option Pfizer Healthcare Ireland has today announced the availability of
Digital Health: Clinical Study Published in “Ophthalmology” Demonstrates Implandata’s EYEMATE System Benefits Glaucoma Patients HANNOVER, Germany, July 27, 2020 /